Compass Therapeutics LLC — Form D/A

Compass Therapeutics LLC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2016-09-21. The offering totals $170.2M, of which $46.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Errik AndersonDirectorCambridge, MA
Ben AuspitzDirectorCambridge, MA
Philip FerneauDirectorHanover, NH
CARL GORDONDirectorSAN DIEGO, CA
Thomas SchuetzDirectorCambridge, MA
Stephen SquintoDirectorStamford, CT
Steve TregayDirectorSan Carlos, CA
Errik AndersonExecutive OfficerCambridge, MA
Thomas SchuetzExecutive OfficerCambridge, MA
Errik AndersonPromoterCambridge, MA
Thomas SchuetzPromoterCambridge, MA
THOMAS J SCHUETZDirectorCAMBRIDGE, MA
THOMAS J SCHUETZExecutive OfficerCAMBRIDGE, MA
THOMAS J SCHUETZPromoterCAMBRIDGE, MA
STEVEN J SQUINTODirectorCAMBRIDGE, MA
CARL J GORDONDirectorCAMBRIDGE, MA
SARA J MANNLEExecutive OfficerCAMBRIDGE, MA
VERED J BISKER-LEIBExecutive OfficerCAMBRIDGE, MA
ERRIK J ANDERSONDirectorCAMBRIDGE, MA
ERRIK J ANDERSONPromoterCAMBRIDGE, MA
BEN J AUSPITZDirectorCAMBRIDGE, MA
BRUCE J STEELDirectorCAMBRIDGE, MA
JEB J LEDELLExecutive OfficerCAMBRIDGE, MA
DAMON J BANKSExecutive OfficerCAMBRIDGE, MA
WILL J EDENDirectorCAMBRIDGE, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2018-07-16D/A$170.2M$110.2M
2018-01-08D$50.0M$21.8M
2015-07-01D$121.0M$16.0M
2015-05-28D/A$1.0M$575K
2014-06-13D$1.0M$475K

More